Therapeutic Area | MeSH |
---|---|
mental disorders | D001523 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VERSACLOZ | Douglas Pharmaceuticals | N-203479 RX | 2013-02-06 | 1 products, RLD, RS |
CLOZARIL | Heritage Life Sciences Barbados | N-019758 RX | 1989-09-26 | 2 products, RLD, RS |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Clozapine, Versacloz, Tasman Pharma | |||
8057811 | 2028-05-01 | DP |
Code | Description |
---|---|
S0136 | Clozapine, 25 mg |
Drug common name | Clozapine |
INN | clozapine |
Description | Clozapine is a psychiatric medication and is the first atypical antipsychotic (also called second-generation antipsychotic) to be discovered. It is primarily used to treat people with schizophrenia and schizoaffective disorder who have had an inadequate response to two other antipsychotics or who have been unable to tolerate other drugs due to extrapyramidal side effects. It is also used for the treatment of psychosis in Parkinson's disease.
|
Classification | Small molecule |
Drug class | tricyclic compounds |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1 |
PDB | — |
CAS-ID | 5786-21-0 |
RxCUI | — |
ChEMBL ID | CHEMBL42 |
ChEBI ID | 3766 |
PubChem CID | 2818 |
DrugBank | DB00363 |
UNII ID | J60AR2IKIC (ChemIDplus, GSRS) |